Kadimastem Granted a Patent in the US for Treatment of Neurodegenerative Diseases
Israeli biotechnology company Kadimastem, announced that it has been granted a patent from the United States Patent and Trademark Office for its technology in the field of cell based…
Read More...
Read More...
